SABA inhaler carbon emissions drop by one-third
NHS England data has shown that average emissions for short-acting beta-2 agonist (SABA) inhalers prescribed in primary care declined by 33% between 2020 and November 2024 — from 24.2 kgCO2e to 16.1 kgCO2e. The Pharmaceutical Journal reports that this fall in SABA inhaler emissions most likely owes to patients switching from the Ventolin Evohaler to the Salamol inhaler.
NICE has produced a decision aid on asthma inhalers and climate change. It explains the options for patients thinking about reducing the carbon footprint of their asthma treatment and the options available.
Related Posts
Bristol Medical Chirurgical Society
The Society which began in 1873 aims to promote the exchange of views between health professionals through education and dialogue. …
New guide launched to tackle overprescribing and problematic polypharmacy
Structured Medication Reviews (SMRs) are the best-tested, NICE-approved intervention to reduce problematic polypharmacy, especially in older people. However, uptake is…